Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
304.6 INR | -0.43% | +0.18% | +21.99% |
May. 17 | Jefferies Adjusts Biocon’s Price Target to INR230 From INR250, Keeps at Underperform | MT |
May. 17 | Biocon's Consolidated Net Profit Declines in Fiscal Q4 | MT |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
4.37B | ||||||
115B | ||||||
106B | ||||||
21.96B | - | |||||
21.87B | - | |||||
19.21B |
- Stock Market
- Equities
- BIOCON Stock
- Charts Biocon Limited
- Sector Chart